Your browser doesn't support javascript.
loading
Successful treatment of a Streptococcus pneumoniae-associated haemolytic uraemic syndrome by eculizumab.
Jeantet, Guillaume; Pernin, Vincent; Brunot, Vincent; Roccabianca, Arnaud; Macombe, Anouk; Szwarc, Ilan; Klouche, Kada; Loirat, Chantal; Mourad, Georges; Frémeaux-Bacchi, Véronique; Le Quintrec, Moglie.
Afiliación
  • Jeantet G; Department of Nephrology and Kidney Transplantation, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.
  • Pernin V; Department of Nephrology and Kidney Transplantation, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.
  • Brunot V; Critical Care Department, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.
  • Roccabianca A; Department of Nephrology and Kidney Transplantation, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.
  • Macombe A; Department of Nephrology and Kidney Transplantation, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.
  • Szwarc I; Department of Nephrology and Kidney Transplantation, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.
  • Klouche K; Critical Care Department, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.
  • Loirat C; Department of Pediatric Nephrology, Hôpital Universitaire Robert Debré, Paris, France.
  • Mourad G; Department of Nephrology and Kidney Transplantation, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.
  • Frémeaux-Bacchi V; Laboratory of Immunology, Hôpital Européen Georges Pompidou, Paris, France.
  • Le Quintrec M; Department of Nephrology and Kidney Transplantation, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.
Clin Kidney J ; 12(1): 106-109, 2019 Feb.
Article en En | MEDLINE | ID: mdl-30746136
Haemolytic uraemic syndrome (HUS) is a rare complication of invasive infection by Streptococcus pneumoniae (SP-HUS), especially in adults. Here we report an unusual case of a 53-year-old man presenting SP-HUS with severe multivisceral involvement. After failure of supportive care and plasma exchanges, eculizumab (anti-C5 antibody) resulted in a favourable outcome.
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Clin Kidney J Año: 2019 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Clin Kidney J Año: 2019 Tipo del documento: Article País de afiliación: Francia